SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
BTX BioTime
An SI Board Since July 2014
Posts SubjectMarks Bans Symbol
69 5 0 BTX
Emcee:  Savant Type:  Moderated
Introduction Market Data Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
19BioTime and its subsidiary OncoCyte announce the online availability oSavant-3/20/2015
18BioTime, Inc. (NYSE MKT: BTX) today announced that the first patient was successSavant-2/24/2015
17BioTime Says U.S. Patent Relating to Proprietary Method Of Manufacturing RPE CelSavant-2/18/2015
16Asterias Biotherapeutics Prices Public Offering of Common Stock 10:37 AM ET 2/5Savant-2/6/2015
15- BioTime subsidiary's data collected from prospective clinical studies in bSavant-2/6/2015
14BioTime, Inc. (NYSE MKT: BTX), Presentation replay for 90 days //a live webcast Savant-12/24/2014
13BioTime Subsidiary ES Cell International and GE Healthcare Cross-License patentsSavant-12/16/2014
12BioTime's Subsidiary Cell Cure Neurosciences Receives FDA Authorization to ISavant-11/3/2014
11 BioTime and subsidiaries to raise $31 mln through sales of ~9.4 mln Savant-10/6/2014
10 BioTime's Subsidiary Cell Cure Neurosciences Ltd. Files an IND wSavant-10/6/2014
9 BioTime's Subsidiary Cell Cure Neurosciences Ltd. Demonstrates tSavant-9/20/2014
8Asterias Biotherapeutics Announces Record Date for Distribution of BioTimSavant-9/10/2014
7MENLO PARK, Calif., Sept. 4, 2014 /PRNewswire/ -- Asterias Biotherapeutics, Inc.Savant-9/5/2014
6 BioTime Subsidiary Asterias Biotherapeutics Receives U.S. FDA ClearaSavant-8/27/2014
5RT...ASTY Asterias Biotherapeutics Announces Investor Briefing ConfeSavant-8/26/2014
4BioTime, Inc. Subsidiary OncoCyte Corporation -2- Jul 31, 2014 09:00:00 (ET) Savant-7/31/2014
3MENLO PARK, Calif., July 24, 2014 /PRNewswire/ -- Asterias Biotherapeutics, Inc.Savant-7/25/2014
2II... BioTime is also developing stem cell and other products for researcSavant-7/14/2014
1BioTime, Inc. (NYSE MKT:BTX) announced today the issuance of 14 new patenSavant-7/14/2014
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News